Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CFN Enterprises Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
23.8
24.1
21.7
0.86
0.51
3.16
4.32
3.54
0.32
0.04
Cost of revenue
8.23
9.07
9.08
0.86
0.54
3.54
6.51
3.02
0.03
0
Gross profit
15.5
15
12.7
0
-0.03
-0.38
-2.19
0.51
0.3
0.04
Research and development
4.02
4.41
4.17
Selling, general and administrative
8.34
1.29
2.24
1.2
2.69
2.64
5.63
2.27
1.75
Selling and marketing
3.61
4.38
4.3
General and administrative
8.34
7.35
8.3
Operating expenses
18.2
16.1
1.29
6.01
1.2
12
6.26
14.3
2.27
1.75
Operating income
-2.65
-1.1
-1.29
-6.01
-1.23
-12.4
-8.45
-13.8
-1.98
-1.71
Interest expense
1.22
1.21
2.58
0.01
0.05
0.09
0.69
1.63
0.22
0.22
Interest income
0.02
0
0
0
0
0.01
0
0
0
0
Other non-operating income
-1.2
-1.32
0
-0.01
-0.11
0.22
-1.47
-1.39
0.12
-0.07
Pre-tax income
-1.29
-6.03
-1.34
-12.2
Income tax
0
0
0
0
0
0
0
Income from continuing operations
-1.29
-6.03
-1.34
-12.2
2.1
2.1
Net income to minority interests
-0.01
-0.02
0
Net income
-3.85
-2.42
-11.4
8.37
-1.59
-12.2
-9.93
-15.2
-4.29
-6.5
EBITDA
-1.89
-0.4
-0.69
-5.97
-1.23
-12
-6.84
-13.7
-1.98
-1.7
EPS, basic
-0.06
-0.04
-0.17
0.10
-0.02
EPS, diluted
-0.06
-0.04
-0.17
0.10
-0.02
Shares, basic (weighted)
65.1
65.4
66.1
84
102
Shares, diluted (weighted)
65.1
65.4
66.1
84
102
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
1.68
0.17
0.03
0.11
0.16
0.17
0.01
0.08
0.37
0.2
Short-term investments
0.05
0.05
0
0
Receivables
2.23
2.69
2.08
0.07
0.01
0.14
0.03
0.94
1.53
0
Inventory
0
0.04
0.16
0
1.8
3.38
0.52
Other current assets
0.4
0.55
0.25
0
0.01
0.12
0
Total current assets
4.36
3.46
2.41
0.18
0.24
0.65
0.06
2.84
5.28
0.8
Property, plant and equipment
0.15
0.07
0.05
0
0.01
5.14
0.05
0.16
0.17
0
Lease right-of-use assets
0.18
Goodwill
0
0
Intangible assets
2.78
3.93
0
0.33
Other non-current assets
0.1
0.12
0.11
Total assets
7.39
7.58
2.57
0.19
0.45
6.69
5.46
8.67
1.23
Accounts payable
2.64
2.48
3.02
0.26
0.22
2
2.36
3.02
7.5
2.92
Accrued liabilities
0.55
1.68
2.34
3.83
6.59
3.43
Deferred revenue
0.05
0.3
0.44
0.02
0.03
0.04
0.01
0.48
0.12
0
Short-term debt
0.19
2.22
Total current liabilities
5.24
7.06
6.86
0.38
1.24
7.3
8.86
17.2
24.5
24.8
Long-term debt
0.48
0.71
1.32
0.98
0.13
0.12
0.11
Lease liabilities
0.48
0.2
1.55
1.87
0.05
Other non-current liabilities
1.49
1.06
0.64
Total liabilities
11.3
12.8
16
0.86
1.96
9.09
10
18.9
26.5
24.9
Total debt
0.5
0.91
3.54
4.07
7.4
7.63
3.5
Paid-in capital
25.2
26.3
29.5
34
34.4
46.4
49.8
60.9
61.1
62
Retained earnings
-29.1
-31.5
-43
-34.7
-36.4
-48.8
-59
-74.4
-79
-85.8
Other comprehensive income
-0.08
-0.04
-0.08
-0.08
0
0
Shareholders' equity
-3.92
-5.22
-13.5
-0.67
-1.51
-2.4
-9.17
-13.4
-17.8
-23.7
Minority interests
0
0.01
0
0
0.06
Total equity
-3.92
-5.22
-13.5
-0.67
-1.51
-2.4
-9.17
-13.4
-17.8
-23.7
Total liabilities and equity
7.39
7.58
2.57
0.19
0.45
6.69
0.87
5.46
8.67
1.23
Shares outstanding
63.4
65.9
66.2
99.7
6.99
31.7
37.6
82.2
8.22
8.58
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-3.85
-2.42
-11.4
8.37
-1.42
-12.2
-9.92
-15.2
-1.86
-1.78
Depreciation and amortization
0.76
0.71
0.6
0.04
0
0.38
1.61
0.06
0
0.01
Stock-based compensation
0.06
0.02
0
1.16
0
Deferred income tax
0
0
Change in receivables
-0.35
-0.35
0.84
-0.24
-0.04
-0.36
0.07
1.1
-0.01
0
Change in inventory
0
0.04
0.49
0.16
-1.8
0
-0.1
Change in payables
-0.46
-0.61
0.22
0.39
0.76
1.55
1.27
2.36
0.27
0.18
Cash from operations
0.32
-1.47
-3.46
-6.97
-0.48
-0.34
-1.42
-4.98
0.44
-0.09
Capital expenditures
-0.02
-0.06
-0.04
-0
-0.01
0
0
Acquisitions
-0.42
0
Purchases of investments
0
-0.2
-0.09
0
Cash from investing
-2.01
-1.78
-1.39
20.5
-0.21
0.02
-0.34
0.58
-0.06
-0.23
Stock issued
0.13
0.01
0.41
0.35
0
Cash from financing
2.52
1.7
4.75
-13.5
0.76
0.33
1.6
4.47
-0.11
0.14
Exchange rate effect
-0.06
0.04
-0.04
-0.01
0
0
Net change in cash
0.77
-1.51
-0.14
0.03
0.07
0.01
-0.16
0.07
0.27
-0.18
Free cash flow
0.3
-1.53
-3.5
-6.97
-0.49
0.44
-0.09
Interest paid
0.49
0.85
1.58
0.96
0
0
0
0
0.29
0.28
Income taxes paid
0
0
0
0
0
0
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.55 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
45.7%
Gross profit / revenue.
Operating margin
-2,099.0%
Operating income / revenue.
EBITDA margin
-2,087.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-2,592.0%
Net income / revenue.
FCF margin
-1,151.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-1,151.0%
Cash from operations / revenue.
Return on assets (ROA)
-587.2%
Net income / average total assets.
SG&A / revenue
-435.8%
Selling, general and administrative expense / revenue.
Capex / revenue
0.0%
Capital expenditures / revenue.
D&A / revenue
12.1%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-88.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-79.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-41.0%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-87.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-119.3%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-119.3%
Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-85.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 5y
22.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.01x
Current assets / current liabilities.
Quick ratio
0.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Debt / assets
490.3%
Total debt / total assets.
Liabilities / assets
3,494.0%
Total liabilities / total assets.
Net debt
$3.5M
Total debt - cash - short-term investments. Negative means more cash than debt.
Market cap + total debt - cash - short-term investments.
P/S
31.9x
Market cap / revenue.
EV/Sales
53.1x
Enterprise value / revenue.
FCF yield
-36.0%
Free cash flow / market cap.
Earnings yield
-81.1%
Net income / market cap (the inverse of P/E).
What was CFN Enterprises Inc.'s revenue in fiscal 2025?
CFN Enterprises Inc. reported revenue of $36.3K for fiscal 2025, 88.7% lower than the year before.
Was CFN Enterprises Inc. profitable in fiscal 2025?
No. It reported a net loss of $6.5M.
How much free cash flow did CFN Enterprises Inc. generate in fiscal 2025?
Cash from operations of $85.6K minus capital expenditures of $0.0 left free cash flow of -$85.6K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.